These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4223122)

  • 21. [Experience with and considerations on therapy of progressive muscular dystrophies].
    Beckmann R
    Hippokrates; 1968 Dec; 39(23):876-88. PubMed ID: 5718770
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of progressive muscular dystrophy].
    Beckmann R
    Med Klin; 1971 Aug; 66(32):1099. PubMed ID: 5562103
    [No Abstract]   [Full Text] [Related]  

  • 23. LAEVADOSIN FOR MUSCULAR DYSTROPHY.
    THOMSON WH
    Br Med J; 1964 Oct; 2(5417):1135-6. PubMed ID: 14198741
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the treatment of progressive muscle dystrophy with an anabolic steroid].
    Ernst K
    Z Arztl Fortbild (Jena); 1966 Apr; 60(7):389-90. PubMed ID: 5983564
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
    Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
    An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on progressive muscular dystrophy. 3. Breakdown of adenosine nucleotides in human blood.
    Nakahara M
    Arzneimittelforschung; 1965 Aug; 15(8):932-4. PubMed ID: 5898654
    [No Abstract]   [Full Text] [Related]  

  • 27. [The treatment of progressive muscular dystrophy (Erb) with adenosine triphosphate].
    STELGENS P
    Dtsch Med Wochenschr; 1957 Oct; 82(41):1761-3. PubMed ID: 13473545
    [No Abstract]   [Full Text] [Related]  

  • 28. [Allopurinol in progressive muscular dystrophy (author's transl)].
    Castro-Gago M; Jiménez JF; Torres-Colomer M; Fuster M; Paz M; Novo I; Peña J
    An Esp Pediatr; 1980 Oct; 13(10):865-76. PubMed ID: 7469188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinico-morphological correlative aspects in progressive muscular dystrophy.
    Andreicuţ S; Dulău E; Popoviciu L; Simu G
    Morphol Embryol (Bucur); 1984; 30(2):123-8. PubMed ID: 6234457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of muscular dystrophy with "laevadosin".
    Hudgson P; Walton JN
    Med J Aust; 1969 Oct; 2(15):776. PubMed ID: 5351054
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significances of the elevated activity of serum creatine phosphokinase and transaminase in progressive muscular dystrophy].
    Kondo F; Ikeda M; Abe E; Mue S
    Iryo; 1966 Jul; 20(7):683-93. PubMed ID: 5981769
    [No Abstract]   [Full Text] [Related]  

  • 32. BIOCHEMICAL CHANGES IN PROGRESSIVE MUSCULAR DYSTROPY. II. PHOSPHORUS METABOLISM IN NORMAL, NUTRITIONAL AND HEREDITARY DYSTROPHIC MUSCLES, LIVERS AND BRAINS OF ANIMALS.
    Sarkar NK; Srivastava U
    J Nutr; 1964 Jul; 83(3):193-201. PubMed ID: 14191419
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum ATP: creatine phosphotransferase in skeleto-muscular disorders with special reference to duchenne muscular dystrophy.
    Griffiths PD
    Guys Hosp Rep; 1965; 114(4):401-20. PubMed ID: 5859368
    [No Abstract]   [Full Text] [Related]  

  • 34. Enzyme changes following prednisone-induced remission in progressive muscular dystrophy.
    Burckhardt D; LaDue JS
    N Y State J Med; 1967 Feb; 67(4):598-9. PubMed ID: 5232108
    [No Abstract]   [Full Text] [Related]  

  • 35. Creatine supplementation results in elevated phosphocreatine/adenosine triphosphate (ATP) ratios in the calf muscle of athletes but not in patients with myopathies.
    Zange J; Kornblum C; Müller K; Kurtscheid S; Heck H; Schröder R; Grehl T; Vorgerd M
    Ann Neurol; 2002 Jul; 52(1):126; author reply 126-7. PubMed ID: 12112063
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the behavior of some serum enzymatic activities in subjects with progressive muscular dystrophy treated with nucleotide and nucleoside substances. II. Malate dehydrogenase, glutamic oxalacetic transaminase and glutamic-pyruvic transaminase activity].
    Canani MB; Rea F; Capasso DA
    Boll Soc Ital Biol Sper; 1965 Aug; 41(16):901-4. PubMed ID: 5880029
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnosis of progressive muscular dystrophy].
    van Wijngaarden GK
    Maandschr Kindergeneeskd; 1970 Feb; 37(10):293-311. PubMed ID: 4906566
    [No Abstract]   [Full Text] [Related]  

  • 39. Hexahydrocoenzyme Q 4 in pseudohypertrophic muscular dystrophy.
    Danowski TS; Folkers K; Wissinger HA; Hohmann TC; Gerneth JA; Vester JW
    J Pharm Sci; 1971 Apr; 60(4):640-2. PubMed ID: 5128384
    [No Abstract]   [Full Text] [Related]  

  • 40. [Histochemistry of skeletal muscle ATPase in neuromuscular diseases, with special reference to progressive muscular dystrophy].
    Tomonaga M; Muro T
    Igaku To Seibutsugaku; 1967 Jul; 75(1):32-6. PubMed ID: 4229920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.